FDA Inspection 1311564 — TEVA Pharmaceuticals USA, Inc.
The FDA completed an inspection of TEVA Pharmaceuticals USA, Inc. on Jul 20, 2026 in Fairfield, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 20, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Fairfield, NJ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 3592 | 21 CFR 211.110(c) | In-process materials characteristics testing |